It proposes a national and long term vision as far as pharmaceutical policy is concerned.
The agreement will have duration of 12-months, with the possibility of it being extended, and will take effect from December 1st
Publication of issue #112 of the Spanish pharmaceutical market in Spain’s Monthly Bulletin
A third of all international approved medicines already have a biological origin
It has been presented before the First Instance Administrative Court in Seville
Farmaindustria considers that it breaches current legislations, and trusts that the Central Government will appeal this measure before the Spanish Constitutional Court